title: BNP in the community - still work to be done...
abstract: The role of brain natriuretic peptide (BNP) as a screening tool for left ventricular systolic dysfunction (LVSD) in primary care remains unclear. We compared the efficacy of BNP with that of a 12 lead electrocardiogram (ECG) as a screening tool for LVSD in the setting of open access echocardiography and found BNP to be more sensitive in excluding LVSD than an ECG. The use of BNP in screening for LVSD resulted in a saving of 10 pounds per patient.
authors.forename: Archana
authors.initials: A
authors.lastname: Rao
authors.forename: Louise
authors.initials: L
authors.lastname: Hodgson
authors.forename: Deborah
authors.initials: D
authors.lastname: Pearce
authors.forename: John
authors.initials: J
authors.lastname: Walsh
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004562:Electrocardiography / Q000191:economics / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000379:methods; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010818:Practice Patterns, Physicians'; D011320:Primary Health Care / Q000191:economics / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D006113:United Kingdom; D018487:Ventricular Dysfunction, Left / Q000097:blood* / Q000175:diagnosis*
chemical_list: D020097:Natriuretic Peptide, Brain